Vulcan Biosciences

Vulcan Biosciences

Vulcan Biosciences, Inc.’s mission is to commercialize a therapy for treating multiple sclerosis (MS), a debilitating disease of the central nervous system. The company is headquartered in Birmingham Alabama and has the appropriate personnel to develop its MS drugs optimally for FDA trials and obtain the financing required to complete this process.